Skip to main content
. 2022 Aug 17;17:143. doi: 10.1186/s13014-022-02117-z

Table 3.

Associations between investigated factors and regain of ambulatory status after treatment

Factor Subgroup (n) Regaining ambulatory status, n (%) p value
Age  ≤ 65 years (190) 11 (6) 0.62
 > 65 years (185) 13 (7)
Interval FD to MSCC  ≤ 15 months (261) 15 (6) 0.43
 > 15 months (114) 9 (8)
Visceral metastases No (90) 9 (10) 0.11
Yes (285) 15 (5)
Further bone metastases No (78) 4 (5) 0.80
Yes (297) 20 (7)
Primary tumor type Breast cancer (31) 1 (3) < 0.001
Prostate cancer (61) 3 (5)
Myeloma/lymphoma (15) 5 (33)
Lung cancer (116) 8 (7)
Other malignancies (152) 7 (5)
Sex Female (112) 9 (8) 0.40
Male (263) 15 (6)
Time developing motor deficits 0–7 days (251) 7 (3) < 0.0001
8–14 days (71) 7 (10)
 > 14 days (53) 10 (19)
ECOG performance score 1–2 (4) 1 (25) 0.23
3–4 (371) 23 (6)
Number of affected vertebrae 1–2 (113) 12 (11) 0.028
 ≥ 3 (262) 12 (5)
Radiotherapy regimen 1 × 8 Gy/5 × 4 Gy (168) 8 (5) 0.24
5 × 5 Gy/longer-course RT (207) 16 (8)
Entire cohort N = 375 24 (6)

FD First diagnosis of malignancy, MSCC Metastatic spinal cord compression, ECOG Eastern Cooperative Oncology Group, RT Radiotherapy

p values were calculated with the Chi-square test or the Fisher’s exact test (for n < 5). When applying Bonferroni adjustment, p values of < 0.005 were considered significant and are given in bold